TY - JOUR
T1 - Training practices of cell processing laboratory staff
T2 - Analysis of a survey by the Alliance for Harmonization of Cellular Therapy Accreditation
AU - Keever-Taylor, Carolyn A.
AU - Slaper-Cortenbach, Ineke
AU - Celluzzi, Christina
AU - Loper, Kathy
AU - Aljurf, Mahmoud
AU - Schwartz, Joseph
AU - Mcgrath, Eoin
AU - Eldridge, Paul
PY - 2015/12/1
Y1 - 2015/12/1
N2 - Background aims: Methods for processing products used for hematopoietic progenitor cell (HPC) transplantation must ensure their safety and efficacy. Personnel training and ongoing competency assessment is critical to this goal. Here we present results from a global survey of methods used by a diverse array of cell processing facilities for the initial training and ongoing competency assessment of key personnel. Methods: The Alliance for Harmonisation of Cellular Therapy Accreditation (AHCTA) created a survey to identify facility type, location, activity, personnel, and methods used for training and competency. A survey link was disseminated through organizations represented in AHCTA to processing facilities worldwide. Responses were tabulated and analyzed as a percentage of total responses and as a percentage of response by region group. Results: Most facilities were based at academic medical centers or hospitals. Facilities with a broad range of activity, product sources and processing procedures were represented. Facilities reported using a combination of training and competency methods. However, some methods predominated. Cellular sources for training differed for training versus competency and also differed based on frequency of procedures performed. Most facilities had responsibilities for procedures in addition to processing for which training and competency methods differed. Although regional variation was observed, training and competency requirements were generally consistent. Conclusions: Survey data showed the use of a variety of training and competency methods but some methods predominated, suggesting their utility. These results could help new and established facilities in making decisions for their own training and competency programs.
AB - Background aims: Methods for processing products used for hematopoietic progenitor cell (HPC) transplantation must ensure their safety and efficacy. Personnel training and ongoing competency assessment is critical to this goal. Here we present results from a global survey of methods used by a diverse array of cell processing facilities for the initial training and ongoing competency assessment of key personnel. Methods: The Alliance for Harmonisation of Cellular Therapy Accreditation (AHCTA) created a survey to identify facility type, location, activity, personnel, and methods used for training and competency. A survey link was disseminated through organizations represented in AHCTA to processing facilities worldwide. Responses were tabulated and analyzed as a percentage of total responses and as a percentage of response by region group. Results: Most facilities were based at academic medical centers or hospitals. Facilities with a broad range of activity, product sources and processing procedures were represented. Facilities reported using a combination of training and competency methods. However, some methods predominated. Cellular sources for training differed for training versus competency and also differed based on frequency of procedures performed. Most facilities had responsibilities for procedures in addition to processing for which training and competency methods differed. Although regional variation was observed, training and competency requirements were generally consistent. Conclusions: Survey data showed the use of a variety of training and competency methods but some methods predominated, suggesting their utility. These results could help new and established facilities in making decisions for their own training and competency programs.
KW - Cellular therapy product processing
KW - Competency
KW - Training
UR - http://www.scopus.com/inward/record.url?scp=84947555062&partnerID=8YFLogxK
U2 - 10.1016/j.jcyt.2015.08.006
DO - 10.1016/j.jcyt.2015.08.006
M3 - Article
AN - SCOPUS:84947555062
SN - 1465-3249
VL - 17
SP - 1831
EP - 1844
JO - Cytotherapy
JF - Cytotherapy
IS - 12
ER -